Advocacy intelligence hub — real-time data for patient organizations
Fudan University — PHASE2
Sun Yat-sen University — PHASE2
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest — PHASE2
Hospital Israelita Albert Einstein — PHASE2
Jiyan Liu — PHASE1
Regina Elena Cancer Institute — PHASE3
The Netherlands Cancer Institute — PHASE2
Shanghai Bovax Biotechnology Co., Ltd. — PHASE3
Universitaire Ziekenhuizen KU Leuven
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Andrea B Apolo
National Cancer Institute LAO
📍 Birmingham, Alabama
Andrea B Apolo, M.D., MD
National Cancer Institute (NCI)
📍 BETHESDA, MD
Hongxia Wang, Doctor
Fudan University
Christian S Hinrichs, MD, M.D
Rutgers Cancer Institute
📍 BETHESDA, MD
Charalampos Floudas, M.D., M.D
National Cancer Institute (NCI)
📍 BETHESDA, MD
Ting Huang
Sichuan Provincial Center for Disease Control and Prevention